Nuo Therapeutics, Inc. cotiza a 1.30 USD y tiene una capitalización bursátil de $63M. En los últimos 12 meses ha facturado $5M con un margen de flujo de caja libre del -34.4%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produc…
| Métrica | AURX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 66.9% | 57.0% | +9.9% |
| Operating Margin | -76.0% | -38.6% | -37.3% |
| Net Margin | -75.8% | -33.6% | -42.3% |
| FCF Margin | -34.4% | -13.9% | -20.5% |
| ROE | — | -40.4% | — |
| ROA | -136.1% | -32.0% | -104.1% |
| Current Ratio | 1.06 | 2.84 | -1.78 |
| Debt / Equity | — | 0.28 | — |